Genetic and pharmacokinetic determinants of response to transdermal nicotine in white, black, and Asian nonsmokers

Clinical Pharmacology and Therapeutics

Volumn 94, Issue 6, 2013, Pages 687-694

  Dempsey, D A ^a,b   St helen, G ^a,b   Jacob, P ^a   Tyndale, R F ^c,d   Benowitz, N L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2A6; NICOTINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; ASIAN; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CAUCASIAN; DIZZINESS; DRUG BLOOD LEVEL; DRUG METABOLISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEART PALPITATION; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MAXIMUM PLASMA CONCENTRATION; NAUSEA; NEGRO; NORMAL HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; TRANSDERMAL PATCH; TREATMENT RESPONSE; VOMITING;

ADMINISTRATION, CUTANEOUS; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ARYL HYDROCARBON HYDROXYLASES; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; NICOTINE; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84888009447     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2013.159     Document Type: Article

References (31)

1. Carmelli, D., Swan, G.E., Robinette, D. & Fabsitz, R. Genetic influence on smoking-a study of male twins. N. Engl. J. Med. 327, 829-833 (1992).
2. Al Koudsi, N. & Tyndale, R.F. Genetic influences on smoking: a brief review. Ther. Drug Monit. 27, 704-709 (2005). (Pubitemid 44391719)
3. Agrawal, A. et al. The genetics of addiction-a translational perspective. Transl. Psychiatry 2, e140 (2012).
4. Benowitz, N.L., Pérez-Stable, E.J., Herrera, B. & Jacob, P. 3rd. Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J. Natl. Cancer Inst. 94, 108-115 (2002). (Pubitemid 34121290)
5. Haiman, C.A. et al. Ethnic and racial differences in the smoking-related risk of lung cancer. N. Engl. J. Med. 354, 333-342 (2006). (Pubitemid 43145058)
6. Trinidad, D.R., Pérez-Stable, E.J., Emery, S.L., White, M.M., Grana, R.A. & Messer, K.S. Intermittent and light daily smoking across racial/ethnic groups in the United States. Nicotine Tob. Res. 11, 203-210 (2009).
7. Hukkanen, J., Jacob, P. 3rd & Benowitz, N.L. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 57, 79-115 (2005). (Pubitemid 40283970)
8. McDonagh, E.M. et al. PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6. Pharmacogenet. Genomics 22, 695-708 (2012).
9. Malaiyandi, V., Sellers, E.M. & Tyndale, R.F. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin. Pharmacol. Ther. 77, 145-158 (2005). (Pubitemid 40269130)
10. Pomerleau, O.F., Pomerleau, C.S. & Namenek, R.J. Early experiences with tobacco among women smokers, ex-smokers, and never-smokers. Addiction 93, 595-599 (1998). (Pubitemid 28188079)
11. DiFranza, J.R. et al. Recollections and repercussions of the first inhaled cigarette. Addict. Behav. 29, 261-272 (2004).
12. Kandel, D.B., Hu, M.C., Griesler, P.C. & Schaffran, C. On the development of nicotine dependence in adolescence. Drug Alcohol Depend. 91, 26-39 (2007). (Pubitemid 47385026)
13. Chen, X. et al. Sensations from initial exposure to nicotine predicting adolescent smoking in China: a potential measure of vulnerability to nicotine. Nicotine Tob. Res. 5, 455-463 (2003). (Pubitemid 37081126)
14. Pomerleau, O.F. Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence. Behav. Genet. 25, 161-177 (1995).
15. Pomerleau, O.F., Collins, A.C., Shiffman, S. & Pomerleau, C.S. Why some people smoke and others do not: new perspectives. J. Consult. Clin. Psychol. 61, 723-731 (1993). (Pubitemid 23304584)
16. Fattinger, K., Verotta, D. & Benowitz, N.L. Pharmacodynamics of acute tolerance to multiple nicotinic effects in humans. J. Pharmacol. Exp. Ther. 281, 1238-1246 (1997). (Pubitemid 27258383)
17. Audrain-McGovern, J., Al Koudsi, N., Rodriguez, D., Wileyto, E.P., Shields, P.G. & Tyndale, R.F. The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics 119, e264-e274 (2007). (Pubitemid 46397834)
18. O'Loughlin, J. et al. Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers. Tob. Control 13, 422-428 (2004). (Pubitemid 39635932)
19. Al Koudsi, N., O'Loughlin, J., Rodriguez, D., Audrain-McGovern, J. & Tyndale, R.F. The genetic aspects of nicotine metabolism and their impact on adolescent dependence. J Pediatr Biochem 1, 105-123 (2010).
20. de Wit, H., Bodker, B. & Ambre, J. Rate of increase of plasma drug level influences subjective response in humans. Psychopharmacology (Berl.) 107, 352-358 (1992).
21. Berridge, M.S., Apana, S.M., Nagano, K.K., Berridge, C.E., Leisure, G.P. & Boswell, M.V. Smoking produces rapid rise of [11C]nicotine in human brain. Psychopharmacology (Berl.) 209, 383-394 (2010).
22. Gries, J.M., Benowitz, N. & Verotta, D. Chronopharmacokinetics of nicotine. Clin. Pharmacol. Ther. 60, 385-395 (1996). (Pubitemid 26356000)
23. Mwenifumbo, J.C. & Tyndale, R.F. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics 8, 1385-1402 (2007). (Pubitemid 350162852)
24. Lunney, P.C. & Leong, R.W. Review article: Ulcerative colitis, smoking and nicotine therapy. Aliment. Pharmacol. Ther. 36, 997-1008 (2012).
25. Thiriez, C., Villafane, G., Grapin, F., Fenelon, G., Remy, P. & Cesaro, P. Can nicotine be used medicinally in Parkinson's disease? Expert Rev. Clin. Pharmacol. 4, 429-436 (2011).
26. Silver, A.A., Shytle, R.D., Philipp, M.K., Wilkinson, B.J., McConville, B. & Sanberg, P.R. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study. J. Clin. Psychiatry 62, 707-714 (2001). (Pubitemid 32994934)
27. Rubinstein, M.L., Shiffman, S., Moscicki, A.B., Rait, M.A., Sen, S. & Benowitz, N.L. Nicotine metabolism and addiction among adolescent smokers. Addiction 108, 406-412 (2013).
28. Stead, L.F. et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 11, CD000146 (2012).
29. Jacob, P. 3rd, Wilson, M. & Benowitz, N.L. Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J. Chromatogr. 222, 61-70 (1981). (Pubitemid 11141159)
30. Schoedel, K.A., Hoffmann, E.B., Rao, Y., Sellers, E.M. & Tyndale, R.F. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 14, 615-626 (2004). (Pubitemid 39281816)
31. Mwenifumbo, J.C., Myers, M.G., Wall, T.L., Lin, S.K., Sellers, E.M. & Tyndale, R.F. Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method. Pharmacogenet. Genomics 15, 189-192 (2005). (Pubitemid 40569906)